Joachim Nozulak

A selective metabotropic glutamate receptor 7 agonist: Activation of receptor signaling via an allosteric site modulates stress parameters<i>in vivo</i>

Kayo Mitsukawa, Rina Yamamoto, Silvio Ofner et al. · Proceedings of the National Academy of Sciences · 2005 · 234 citations · Full text

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat

Eric P. Zorrilla, Glenn R. Valdez, Joachim Nozulak et al. · Brain Research · 2002 · 159 citations

Stress Hormone, Behavioral Neuroscience, Medicine +12

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Dominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe et al. · Neuropharmacology · 2008 · 127 citations

Synaptic Transmission, Neurotransmitter, Synaptic Signaling +16

(+)-cis-4,5,7a,8,9,10,11,11a-Octahydro-7H-10-methylindolo[1,7-bc][2,6]- naphthyridine: A 5-HT2C/2B Receptor Antagonist with Low 5-HT2A Receptor Affinity

Joachim Nozulak, Hans O. Kalkman, Philipp Floerscheim et al. · Journal of Medicinal Chemistry · 1995 · 61 citations · Full text

Medicinal Chemistry, 5-Ht2c/2b Receptor Antagonist, Biochemistry +14

5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes

Anne T. Bruinvels, Hugues Lery, Joachim Nozulak et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1992 · 55 citations

Molecular Pharmacology, Human Brain Membranes, Neurophysiology +13